Multiple hyperplastic polyps in the stomach: Evidence for clonality and neoplastic potential

被引:35
作者
Dijkhuizen, SMM
Entius, MM
Clement, MJ
Polak, MM
VandenBerg, FM
Craanen, ME
Slebos, RJC
Offerhaus, GJA
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,DEPT PATHOL,NL-1105 AZ AMSTERDAM,NETHERLANDS
[2] UNIV AMSTERDAM,ACAD MED CTR,DEPT GASTROENTEROL,NL-1105 AZ AMSTERDAM,NETHERLANDS
关键词
D O I
10.1053/gast.1997.v112.pm9024310
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The origin and neoplastic potential of gastric epithelial polyps remains an area of great interest, and treatment choices are a topic of controversy. This report describes a patient diagnosed with three concurrent hyperplastic gastric polyps that were studied for genetic alterations. The polyps were investigated for alterations in the K-ras oncogene and the p53 tumor suppressor gene and for p21(WAF1/Cip1) and MDM2 protein overexpression. In addition, loss of heterozygosity at several loci that are frequently involved in human cancer was analyzed, microsatellite instability, a hallmark of the ''mutator'' phenotype, was determined, and Epstein-Barr virus infection was investigated. All separate areas from the three independent polyps harbored the same activating point mutation in codon 12 of the K-ras oncogene, indicating a clonal origin. DNA sequence alterations in p53 were not found, although high p53 protein levels could be shown by immunohistochemistry in areas of carcinoma within the largest polyp. No alterations in any of the other molecular markers were observed. The results strongly favor a clonal origin of the three independent gastric polyps and support the notion that these hyperplastic polyps may carry a risk for malignancy.
引用
收藏
页码:561 / 566
页数:6
相关论文
共 41 条
[1]   The WAF1-mediated p53 growth-suppressor pathway is intact in the coronary arteries of heart transplant recipients [J].
Baas, IO ;
Offerhaus, JA ;
ElDeiry, WS ;
Wu, TC ;
Hutchins, GM ;
Kasper, EK ;
Baughman, KL ;
Baumgartner, WA ;
Chiou, CJ ;
Hayward, GS ;
Hruban, RH .
HUMAN PATHOLOGY, 1996, 27 (04) :324-329
[2]   EVALUATION OF 6 ANTIBODIES FOR IMMUNOHISTOCHEMISTRY OF MUTANT P53 GENE-PRODUCT IN ARCHIVAL COLORECTAL NEOPLASMS [J].
BAAS, IO ;
MULDER, JWR ;
OFFERHAUS, GJA ;
VOGELSTEIN, B ;
HAMILTON, SR .
JOURNAL OF PATHOLOGY, 1994, 172 (01) :5-12
[3]  
BAKER SJ, 1990, CANCER RES, V50, P7717
[4]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[5]   THE PATHOLOGY OF CRONKHITE-CANADA POLYPS - A COMPARISON TO JUVENILE POLYPOSIS [J].
BURKE, AP ;
SOBIN, LH .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1989, 13 (11) :940-946
[6]  
CORREA P, 1988, CANCER RES, V48, P3554
[7]   CHRONOLOGY OF P53 PROTEIN ACCUMULATION IN GASTRIC CARCINOGENESIS [J].
CRAANEN, ME ;
BLOK, P ;
DEKKER, W ;
OFFERHAUS, GJA ;
TYTGAT, GNJ .
GUT, 1995, 36 (06) :848-852
[8]   ABSENCE OF RAS GENE-MUTATIONS IN EARLY GASTRIC CARCINOMAS [J].
CRAANEN, ME ;
BLOK, P ;
TOP, B ;
BOERRIGTER, L ;
DEKKER, W ;
OFFERHAUS, GJA ;
TYTGAT, GNJ ;
RODENHUIS, S .
GUT, 1995, 37 (06) :758-762
[9]  
CROFT D N, 1963, Br Med J, V2, P897
[10]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825